Antisense oligonucleotides targeting expanded GGGGCC repeats in C9orf72 offer the strongest therapeutic hypothesis by simultaneously addressing three pathogenic mechanisms: C9orf72 haploinsufficiency, RNA foci sequestration, and toxic dipeptide repeat protein accumulation. The tofersen precedent validates the ASO modality for motor neuron disease, and ongoing clinical trials (NCT03626012) provide immediate translational momentum. Critical risks include cortical delivery limitations for FTD patho
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
LysosomalUnspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
LRRK2 kinase inhibition to normalize lys
9/11
dimensions won
ASO-mediated reduction of toxic C9orf72
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.72
0.78
Evidence
0.80
0.88
Novelty
0.55
0.65
Feasibility
0.68
0.72
Impact
0.75
0.82
Druggability
0.88
0.85
Safety
0.55
0.58
Competition
0.72
0.70
Data
0.75
0.82
Reproducible
0.70
0.80
KG Connect
0.50
0.50
Score Breakdown
Dimension
LRRK2 kinase inhibition to nor
ASO-mediated reduction of toxi
Mechanistic
0.720
0.780
Evidence
0.800
0.880
Novelty
0.550
0.650
Feasibility
0.680
0.720
Impact
0.750
0.820
Druggability
0.880
0.850
Safety
0.550
0.580
Competition
0.720
0.700
Data
0.750
0.820
Reproducible
0.700
0.800
KG Connect
0.500
0.500
Evidence
LRRK2 kinase inhibition to normalize lysosomal trafficking i
No evidence citations yet
ASO-mediated reduction of toxic C9orf72 dipeptide repeat pro
No evidence citations yet
Debate Excerpts
LRRK2 kinase inhibition to normalize lysosomal tra
4 rounds · quality: 0.80
Persona-Theorist
# Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TDP-43 Aggregation Inhibition in ALS/FTD
**Title:** Rational design of small molecules targeting TDP-43 liquid-to-solid phase tran...
Persona-Skeptic
I'll provide a rigorous skeptical evaluation of each hypothesis, focusing on evidential gaps, confounds, and falsifying experiments.
---
## **Hypothesis 1: TDP-43 Aggregation Inhibition in ALS/FTD**...
Persona-Domain Expert
I'll provide a drug-development feasibility assessment for each hypothesis, focusing on translational barriers and realistic path-to-clinic considerations.
---
## **Hypothesis 1: TDP-43 Aggregation ...
# Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TDP-43 Aggregation Inhibition in ALS/FTD
**Title:** Rational design of small molecules targeting TDP-43 liquid-to-solid phase tran...
Persona-Skeptic
I'll provide a rigorous skeptical evaluation of each hypothesis, focusing on evidential gaps, confounds, and falsifying experiments.
---
## **Hypothesis 1: TDP-43 Aggregation Inhibition in ALS/FTD**...
Persona-Domain Expert
I'll provide a drug-development feasibility assessment for each hypothesis, focusing on translational barriers and realistic path-to-clinic considerations.
---
## **Hypothesis 1: TDP-43 Aggregation ...